ArticleClinical pharmacology : advances and applications2013

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure.

Kaori Yabuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.